Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Major Program

Phase 0 I II Cancer Prevention Clinical Trials Program

Research Group

Gastrointestinal and Other Cancers

Status

Active, not recruiting

NCT ID

NCT02968810

This phase II trial studies how well simvastatin works in preventing liver cancer in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Intervention

Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin

Condition

Cirrhosis, Hepatocellular Carcinoma

Investigators

Marc T Goodman

See list of participating sites